Winton Capital »

Protalix Biotherapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $131k 56k 2.33

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Protalix Biotherapeutics

BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Vanguard Portfolio Management
Stratos Wealth Partners
Dimensional Fund Advisors
Goldman Sachs Group
Marshall Wace
Citadel Advisors
Susquehanna International
Morgan Stanley
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Bank of New York Mellon

View all funds holding Protalix Biotherapeutics